Immune thrombocytopenia in late pregnancy requires specialized care
A study presents six cases of pregnant women with severe ITP, highlighting the importance of individualized treatment to improve outcomes.
A study presents six cases of pregnant women with severe ITP, highlighting the importance of individualized treatment to improve outcomes.
Prednisone is sometimes prescribed as a treatment for FNAIT, but in some patients, it can lead to gestational diabetes.
In areas where the MAIPA test is unavailable, platelet crossmatching can be a useful tool for diagnosing FNAIT.
Learn more about why IVIG is recommended for pregnancies at risk of FNAIT and why some patients may need more infusions than others.
A clinical trial sponsored by Johnson & Johnson will seek to determine whether nipocalimab prevents or delays FNAIT in at-risk pregnancies.
A recent study found that severe maternal thrombocytopenia may increase the risk of neonatal thrombocytopenia.
A study by Rallybio is currently underway to determine whether the risk of FNAIT differs by race or ethnicity.
Although rare, thrombocytopenia is an adverse effect that may be associated with intravenous immunoglobulin therapy, a recent study found
Recent strategies have emerged to improve the quality and supply of platelets for transfusions, a key treatment for patients with FNAIT.
A recent study found that children with FNAIT may be at an elevated risk of developing autism later in childhood, regardless of ICH status.